Lanthanide upconversion nonlinearity: a key probe feature for background-free deep-tissue imaging
Authors:
Niusha Bagheri,
Chenyi Wang,
Du Guo,
Anbharasi Lakshmanan,
Qi Zhu,
Nahid Ghazyani,
Qiuqiang Zhan,
Georgios A. Sotiriou,
Haichun Liu,
Jerker Widengren
Abstract:
Lanthanide-based upconversion nanoparticles (UCNPs) have attracted considerable attention in biomedical applications, largely due to their anti-Stokes shifted emission enabling autofluorescence-free signal detection. However, residual excitation light can still interfere with their relatively low brightness. While commonly used lock-in detection can distinguish weak signals from substantial random…
▽ More
Lanthanide-based upconversion nanoparticles (UCNPs) have attracted considerable attention in biomedical applications, largely due to their anti-Stokes shifted emission enabling autofluorescence-free signal detection. However, residual excitation light can still interfere with their relatively low brightness. While commonly used lock-in detection can distinguish weak signals from substantial random background, concurrently modulated residual excitation light is not eliminated. This remains a challenge, particularly under demanding experimental conditions.
Here, we explore the inherent nonlinear response of UCNPs and discover that UCNPs can act as frequency mixers in response to intensity-modulated excitation. Particularly, modulated excitation with more than one base modulation frequency can generate additional low-frequency beating-signals. We show how these signals are resolvable by low-speed detectors such as cameras, are devoid of ambient and residual excitation light, and how they can be enhanced through nanoparticle engineering. Detection of beating-signals thus provides a strategy to significantly enhance signal-to-background conditions in UCNP-based bioimaging and biosensing.
△ Less
Submitted 7 March, 2025;
originally announced March 2025.
Antibody-loading of biological nanocarrier vesicles derived from red-blood-cell membranes
Authors:
Maryam Sanaee,
K. Göran Ronquist,
Elin Sandberg,
Jane M. Morrell,
Jerker Widengren,
Katia Gallo
Abstract:
Antibodies, disruptive potent therapeutic agents against pharmacological targets, face a barrier crossing immune-system and cellular-membranes. To overcome these, various strategies have been explored including shuttling via liposomes or bio-camouflaged nanoparticles. Here, we demonstrate the feasibility to load antibodies into exosome-mimetic nanovesicles derived from human red-blood-cell-membran…
▽ More
Antibodies, disruptive potent therapeutic agents against pharmacological targets, face a barrier crossing immune-system and cellular-membranes. To overcome these, various strategies have been explored including shuttling via liposomes or bio-camouflaged nanoparticles. Here, we demonstrate the feasibility to load antibodies into exosome-mimetic nanovesicles derived from human red-blood-cell-membranes. The goat-anti-chicken antibodies are loaded into erythrocyte-membrane derived nanovesicles and their loading yields are characterized and compared with smaller dUTP-cargo. Applying dual-color coincident fluorescence burst methodology, the loading yield of nanocarriers is profiled at single-vesicle level overcoming their size-heterogeneity and achieving a maximum of 38-41% antibody-loading yield at peak radius of 52 nm. The average of 14 % yield and more than two antibodies per vesicle is estimated, comparable to those of dUTP-loaded nanovesicles after additional purification through exosome-spin-column. These results suggest a promising route for enhancing biodistribution and intracellular accessibility for therapeutic antibodies using novel, biocompatible, and low-immunogenicity nanocarriers, suitable for large-scale pharmacological applications.
△ Less
Submitted 6 December, 2023;
originally announced December 2023.
